Changing Faces: agency, consultant, and investor hires from November 2022
DECEMBER 14, 2022
Last month we saw some movement in the pharma world, but also in some of the orbiting worlds of agencies, consultancies, and pharma investors. Drug development consultancy Boyds has tapped Dr Patrick Ginty as senior director of regulatory affairs.
Let's personalize your content